Amyotrophic lateral sclerosis (ALS) is characterized by pathological aggregation of TDP-43 in motor neurons → motoneuronal inflammation-mecanisme-cle-ginger-sucre-explication-2026">NF-κB → microglial neuroinflammation (NLRP3/IL-1β) → progressive loss of upper and lower motor neurons. An emerging gut-motor neuron axis shows severe dysbiosis in ALS (↓ Butyrivibrio/Roseburia, ↑ Cyanobacteria/BMAA neurotoxin) → LPS → TLR4/NF-κB spinal → microgliosis. 6-gingerol inhibits motoneuronal NF-κB, activates Nrf2 (mitochondrial protection) and reduces microglial NLRP3. INTI Elixir: <1.19g sugar/100ml — minimal inflammatory load in this devastating pathology. ⚠️ ALS is a severe progressive disease — ginger is a food supplement, never a treatment. Do not change riluzole or edaravone without a neurologist.
ALS: molecular mechanisms of motor neuron degeneration
ALS affects ~1,000 new cases per year in Belgium (prevalence ~3,000). Median survival 3-5 years after diagnosis. Key mechanisms:
- Pathological TDP-43: TDP-43 (transcription/splicing factor) forms ubiquitinyl-aggregates in the cytoplasm of motor neurons → loss of nuclear function + toxic cytoplasmic effect. Present in >97% of sporadic cases (sALS). TARDBP mutations cause familial forms.
- NF-κB motoneuronal: TDP-43 aggregates → ER cortisol-natural-relief">stress (UPR) → NF-κB → motoneuronal TNF-α/IL-1β → mitochondrial apoptosis. NF-κB also activated in surrounding astrocytes and microglia → amplified neuroinflammation.
- NLRP3 microglial ALS: LPS/ATP/TDP-43 aggregates → microglial NLRP3 → IL-1β/IL-18 → astrocytic pyroptosis → glutamate excitotoxicity (NMDA/AMPA → Ca²⁺ ↑ → motor neuron death).
- Gut-motor neuron axis: Recent studies (Univ. Columbia 2022): dysbiosis in ALS correlates with progression — ↓ Butyrivibrio fibrisolvens, ↑ Cyanobacteria (BMAA producer — β-methylamino-L-alanine, neurotoxin). Systemic LPS → TLR4/NF-κB spinal → ventral horn cells microgliosis.
INTI vs GIMBER — ALS
| ALS criterion | INTI Elixir | GIMBER |
|---|---|---|
| Sugar (NLRP3/NF-κB) | 1.19g/100ml | ~35g/100ml → NLRP3 neural fuel |
| Gut-motor neuron axis | Polyphenols → Butyrivibrio ↑, LPS ↓ | Sugar → dysbiosis ALS ↑, BMAA ↑ |
| Nrf2/antioxidant | 6-shogaol → Nrf2 ↑ | Sugar → accelerated Nrf2 depletion |
| Dysphagia compatibility | Liquid — easy to dilute | Sugar load problematic |
- Riluzole (Rilutek) — metabolized by CYP1A2. Ginger can slightly inhibit CYP1A2 → possible increase in riluzole concentration. Clinical monitoring. Always validate with a neurologist.
- Edaravone (Radicava) — IV antioxidant. Ginger (Nrf2/HO-1) could theoretically be synergistic. No clinical study available. Caution.
- ALS dysphagia — 85% of ALS patients develop swallowing difficulties. Dilute INTI in 150ml of water. After PEG: consult ALS team for feeding tube modalities.
- Ginger does not slow down ALS progression — no human clinical study available. May improve digestive comfort, constipation, and systemic inflammatory profile.
FAQ — ALS & Ginger (7 questions)
Q1: Can ginger stop ALS?
No — no treatment stops ALS. Ginger (6-gingerol) can modulate neuroinflammation (NLRP3 ↓, NF-κB ↓) and improve the gut-motor neuron axis, but no human clinical study ALS/ginger available. It is a food supplement, not a disease-modifying treatment.
Q2: What is TDP-43 and why is it central to ALS?
TDP-43 is a nuclear RNA-binding protein. In ALS (>97% of cases), it forms ubiquitinyl-cytoplasmic aggregates in motor neurons → loss of mRNA regulation + NF-κB activation + ER stress → progressive motor neuron death.
Q3: What is BMAA and why is it dangerous in ALS?
BMAA (β-methylamino-L-alanine) is a neurotoxin produced by intestinal Cyanobacteria. In ALS, Cyanobacteria increase → BMAA → protein misfolding → TDP-43-like aggregates. Sugar (GIMBER 35g) promotes Cyanobacteria growth — doubly problematic in ALS.
Q4: Riluzole and ginger — interaction to fear?
Riluzole is metabolized by CYP1A2. Ginger can slightly inhibit CYP1A2 (at high doses). At INTI dose (3cl), this interaction is likely minimal but should be reported to the neurologist who monitors riluzole tolerability (transaminases).
Q5: Dysphagia in ALS — how to use INTI?
Dilute INTI 3cl in 150ml of lukewarm water. Liquid consistency. For severe dysphagia: speech therapy advice for fluid thickening. After PEG: consult ALS team for administration modalities.
Q6: Is the gut-motor neuron axis really documented in ALS?
Yes — studies 2019-2023 (Univ. Columbia, Front. Neurol.) show specific ALS dysbiosis correlating with progression. Microbiome transplantation from ALS patients to SOD1 mice accelerates the phenotype. The gut is a real target in ALS.
Q7: Where to find INTI in Belgium for an ALS patient?
INTI available on inti-drink.com and Belgian pharmacies/health food stores. Liquid concentrate to dilute — suitable for mild-moderate dysphagia. 1.19g sugar, alcohol-free.
GIMBER: 35g sugar → NLRP3 neural fuel + Cyanobacteria/BMAA ↑ + Nrf2 depletion
INTI: 1.19g sugar → NF-κB motoneuronal ↓ + Butyrivibrio ↑ + Nrf2/HO-1 protection
⚠️ Food supplement only — Under neurological supervision
Discover INTI — 1.19g sugar
Related articles
Read more about related topics :
- ginger and Parkinson's-belgie-alpha-synucleine-nlrp3-dopamine-darm-hersen-as-gember-2025">Parkinson's Disease & Ginger : α-Synuclein, NLRP3, Dopamine and Gut-Brain Axis | INTI Belgium
- Autoimmune Hepatitis (AIH) & Ginger : Hepatic NF-κB, Treg and Liver Microbiome | INTI Belgium
- Primary Biliary Cholangitis (PBC) & Ginger : Biliary NF-κB, Bile Acids and Hepatic Microbiome | INTI Belgium
- Dermatomyositis & Polymyositis : IFN-α, Muscular NF-κB, MDA5 and Microbiome | INTI Belgium
- Diabetic Nephropathy & Ginger : Glomerular NF-κB, TGF-β and Renal Microbiome | INTI Belgium
- cortisol-nfkb-gember-2025">Belgian Police Officers & Ginger : Chronic Stress, PTSD, ginger cortisol and NF-κB | INTI Belgium
- Psoriatic Arthritis & Ginger : IL-17A, TNF-α, ginger skin-Joint Axis and Microbiome | INTI Belgium
- POTS & Postural Dysautonomia : Autonomic NF-κB, RAAS and Microbiome | INTI Belgium